Icagen, Inc. (Nasdaq: ICGN) 39.6% HIGHER; today reported positive results in its Phase IIa epilepsy study of ICA-105665, the Company's novel orally available small molecule KCNQ potassium channel agonist. Click here to see the full report.
Xfone (NYSE: XFN) 28% HIGHER; the stock is continuing higher today following a 15% jump yesterday. Technicians may be buying the stock today on a possible breakout as it seems that the $1.50 level previously served as a strong level of technical resistance....
Post new comment